RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Eurobio Scientific Stock

Eurobio Scientific Debt 2025

Eurobio Scientific Debt

10.98 EUR

Ticker

ALERS.PA

ISIN

FR0013240934

WKN

A2DVTN

In 2025, Eurobio Scientific's total debt was 10.98 EUR, a -10.51% change from the 12.27 EUR total debt recorded in the previous year.

Eurobio Scientific Aktienanalyse

What does Eurobio Scientific do?

Eurobio Scientific SA is a French company specializing in the development and marketing of diagnostic and research products in the field of biology. It was founded in 2007 as a spin-off from the Pierre and Marie Curie University and is headquartered in Paris. Since 2017, the company has been listed on Euronext Growth in Paris. The company's business model is based on clear divisional structure with various product lines, including clinical diagnostics, research diagnostics, blood bank diagnostics, food analysis, and animal health research. Eurobio Scientific SA operates in over 60 countries and has a strong presence in Europe and Asia. Its notable products include the COVID-19 antibody test ELISA, a rapid COVID-19 test based on immuno-chromatography, and an All-In-One PCR test system for detecting COVID-19. This system allows for the rapid identification of the virus through a single reaction tube. Overall, Eurobio Scientific SA is an innovative company committed to constant product development and improvement, and its diverse product portfolio and international presence highlight its strength and position as an emerging player in the field of diagnostic and research products. Eurobio Scientific ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Eurobio Scientific's Debt Structure

Eurobio Scientific's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Eurobio Scientific's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Eurobio Scientific’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Eurobio Scientific’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Eurobio Scientific stock

What is the debt of Eurobio Scientific this year?

Eurobio Scientific has a debt level of 10.98 EUR this year.

What was the debt of Eurobio Scientific compared to the previous year?

The debt of Eurobio Scientific has increased by -10.51% compared to the previous year dropped.

What are the consequences of high debt for investors in Eurobio Scientific?

High debt can pose a risk for investors of Eurobio Scientific, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Eurobio Scientific?

Low debt means that Eurobio Scientific has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Eurobio Scientific affect the company?

An increase in debt of Eurobio Scientific can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Eurobio Scientific affect the company?

A reduction in debt of Eurobio Scientific can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Eurobio Scientific?

Some factors that can influence the debt of Eurobio Scientific include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Eurobio Scientific so important for investors?

The debts of Eurobio Scientific are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Eurobio Scientific take to change the debt?

To change the debt, Eurobio Scientific can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Eurobio Scientific pay?

Over the past 12 months, Eurobio Scientific paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Eurobio Scientific is expected to pay a dividend of 0 EUR.

What is the dividend yield of Eurobio Scientific?

The current dividend yield of Eurobio Scientific is .

When does Eurobio Scientific pay dividends?

Eurobio Scientific pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Eurobio Scientific?

Eurobio Scientific paid dividends every year for the past 0 years.

What is the dividend of Eurobio Scientific?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Eurobio Scientific located?

Eurobio Scientific is assigned to the 'Health' sector.

Wann musste ich die Aktien von Eurobio Scientific kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Eurobio Scientific from 8/21/2025 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 8/21/2025.

When did Eurobio Scientific pay the last dividend?

The last dividend was paid out on 8/21/2025.

What was the dividend of Eurobio Scientific in the year 2024?

In the year 2024, Eurobio Scientific distributed 0 EUR as dividends.

In which currency does Eurobio Scientific pay out the dividend?

The dividends of Eurobio Scientific are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Eurobio Scientific

Our stock analysis for Eurobio Scientific Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Eurobio Scientific Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.